BIOMAT Database Logo BIOMAT Database Logo

Ototoxicity of erythromycin lactobionate. 1979

W Lornoy, and J Steyaert

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003051 Cochlea The part of the inner ear (LABYRINTH) that is concerned with hearing. It forms the anterior part of the labyrinth, as a snail-like structure that is situated almost horizontally anterior to the VESTIBULAR LABYRINTH. Cochleas
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006312 Hearing Loss, Bilateral Partial hearing loss in both ears. Deafness Bilateral,Bilateral Deafness,Bilateral Hearing Loss,Bilateral Hearing Losses,Bilateral, Deafness,Bilaterals, Deafness,Deafness Bilaterals,Deafness, Bilateral,Loss, Bilateral Hearing
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014722 Vestibule, Labyrinth An oval, bony chamber of the inner ear, part of the bony labyrinth. It is continuous with bony COCHLEA anteriorly, and SEMICIRCULAR CANALS posteriorly. The vestibule contains two communicating sacs (utricle and saccule) of the balancing apparatus. The oval window on its lateral wall is occupied by the base of the STAPES of the MIDDLE EAR. Vestibular Apparatus,Ear Vestibule,Vestibular Labyrinth,Vestibule of Ear,Vestibulum Auris,Apparatus, Vestibular,Ear Vestibules,Labyrinth Vestibule,Labyrinth Vestibules,Labyrinth, Vestibular,Labyrinths, Vestibular,Vestibular Labyrinths,Vestibule, Ear,Vestibules, Ear,Vestibules, Labyrinth
D034381 Hearing Loss A general term for the complete or partial loss of the ability to hear from one or both ears. Deafness, Transitory,Hearing Impairment,Hearing Loss, Transitory,Hypoacusis,Transitory Hearing Loss,Deafnesses, Transitory,Hypoacuses,Loss, Hearing,Loss, Transitory Hearing,Transitory Deafness,Transitory Deafnesses,Transitory Hearing Losses

Related Publications

W Lornoy, and J Steyaert
Pharmacokinetics of intravenous erythromycin lactobionate.
January 1980, The Journal of international medical research,
W Lornoy, and J Steyaert
Erythromycin ototoxicity.
September 1982, The Medical journal of Australia,
W Lornoy, and J Steyaert
Erythromycin ototoxicity.
July 2003, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,
W Lornoy, and J Steyaert
Erythromycin ototoxicity.
February 1980, The Journal of otolaryngology,
W Lornoy, and J Steyaert
[Ototoxicity of erythromycin].
December 1979, Nederlands tijdschrift voor geneeskunde,
W Lornoy, and J Steyaert
Ototoxicity of erythromycin.
May 1978, Lancet (London, England),
W Lornoy, and J Steyaert
Ototoxicity of erythromycin.
July 1978, Lancet (London, England),
W Lornoy, and J Steyaert
Erythromycin lactobionate toxicity in preterm neonates.
February 1994, The Pediatric infectious disease journal,
W Lornoy, and J Steyaert
Erythromycin-induced ototoxicity.
June 1983, Mayo Clinic proceedings,
W Lornoy, and J Steyaert
Reversible erythromycin ototoxicity.
February 2007, Prescrire international,
Copied contents to your clipboard!